Dark History, Bright Future?: The Ethical Conundrum of Eugenics and Genomics
By Alexander Capron
| 04. 26. 2007
A talk given at the ESRC Genome Policy and Research Forum at the University of Edinburgh, Scotland
It is a cliché to suggest that we are standing at the edge of a new age, but in terms of genetic science, that cliché is an understatement. Just as the great gains in theory and methodology achieved by physicists early in the 20th century produced both an exponential growth in understanding and applications of that knowledge that transformed human affairs, so the work of genetic researchers in the last decade of the 20th century set the stage for what I am sure we all agree will be equally astonishing theoretical and practical transformations in biology in this century.
There has, of course, been a great deal of hype as well. The tendency to claim "breakthrough" for every research finding, especially those related to grave human diseases, is visible on a daily basis in the media, as well as in more scientific settings. This tendency, which is born both of intellectual excitement and simple pride, driven as well by the competition for research funding and by the imperatives of University publicity departments, carries the potential for backlash.
Yet, even if...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Susanna Smith, Genetic Frontiers | 07.28.2025
Key Topics
How does the American far right view genetics and genetic technologies?
What is the history of the American cultural pursuit of trying to choose smarter children? What has science shown us about the relationship of heredity and intelligence...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...